Source https://www.uu.se/en/news/2024/2024-03-15-groundbreaking-research-into-psychedelic-therapy
PsyPal, as the study is called, is coordinated by the University Medical Center Groningen, the Netherlands, and is the first of its kind to receive EU funding. Uppsala University is one of the institutions participating in the study.
Inna Feldman, Docent of Health Economics at the Department of Public Health and Caring Sciences, will contribute her expertise to the project.
“This is the first study in Europe to explore this type of treatment for end-of-life patients. The aim is to determine whether patients with advanced Chronic Obstructive Pulmonary Disorder (COPD), MS, ALS and atypical Parkinson’s can achieve a better quality of life with psilocybin therapy. It’s about helping patients live as well as possible, for as long as possible,” says Inna Feldman.
Read more https://www.uu.se/en/news/2024/2024-03-15-groundbreaking-research-into-psychedelic-therapy
